Metraipolis › archive › dc_9cebcafad474

USP1 driven mitotic dysregulation and PLK1 stabilization confer Lenvatinib resistance in hepatocellular carcinoma — Europe PMC PMID:41820949

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41820949
DOI
10.1186/s13046-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-04T11:18:15.256Z
SHA-256 of the archived text
bc2fb9fd8594fb1a248506a62c33885445b7cd62c4d5d63c9d0bd5e66a637602
Stable URL of this page
https://metraipolis.com/documento/dc_9cebcafad474

How to cite

USP1 driven mitotic dysregulation and PLK1 stabilization confer Lenvatinib resistance in hepatocellular carcinoma — Europe PMC PMID:41820949 — Europe PMC (en), https://europepmc.org/article/MED/41820949 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9cebcafad474 (Metraipolis archive dc_9cebcafad474, sha256 bc2fb9fd8594fb1a248506a62c33885445b7cd62c4d5d63c9d0bd5e66a637602)
BibTeX
@misc{dc9cebcafad474,
  title = {USP1 driven mitotic dysregulation and PLK1 stabilization confer Lenvatinib resistance in hepatocellular carcinoma — Europe PMC PMID:41820949},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41820949},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9cebcafad474; sha256 bc2fb9fd8594fb1a248506a62c33885445b7cd62c4d5d63c9d0bd5e66a637602},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41820949. Agents can read the archived copy with the MCP tool read_document.